Primary prevention of arteriosclerotic cardiovascular disease (ASCVD) is a desirable but challenging goal to attain. Several strategies to delay the onset of clinically meaningful ASCVD have been proposed, however, clinical application of these strategies is patchy at best.
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.